1[1]Conlon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates[J]. J Exp Zool, 1996, 275(2-3): 226-38.
2[2]Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning ofcDNA encoding the urotensin Ⅱ precursor in frog and human reveals expression of urotensin Ⅱ gene in motoneurons of the spinal cord [J]. Proc Natl Acad Sci USA, 1998, 95(26): 15803-8.
3[3]Ames RS, Sarau HM, Chambers JK, et al. Human urotensin- Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J]. Nature, 1999, 401(6750): 282-6.
4[5]Dschietzig T, Richter C, Bartsch C, et al. Flow-induced pressure differentially regulates endothelin-1, urotensin Ⅱ, adrenomedullin, and relaxin in pulmonary vascular endothelium [J]. BiochemBiophys Res Commun, 2001, 289(1): 245-51.
5[6]Bond H, Winter MJ, Warne JM, et al. Plasma concentrations of arginine vasotocin and urotensin Ⅱ are reduced following transfer of the euryhaline flounder (Platichthys flesus) from seawater to fresh water[J]. Gan Comp Endocrinol, 2002, 125(1): 113-20.
6[7]Liu Q, Pong SS, Zeng Z, et al. Identification ofurotensin Ⅱ as theendogenous ligand for the orphan G-protein-coupled receptor GPR14[J]. Biochem Biophys Res Commun, 1999, 226(1): 174-8.
7[9]Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin Ⅱ: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 [ J ]. Br J Pharmacol, 2000, 131(3): 441-6.
8[10]Maclean MR, Alexander D, Stirrrat A, et al. Contractile responses to human urotensin- Ⅱ in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat [J]. Br J Pharmacol, 2000, 130(2): 201-4.
9[11]Douglas SA, Sulpizio AC, Piercy V, et al. Differential vasocons trictor activity of human urotensin- Ⅱ in vascular tissue isolated from the rat, mouse, dog, pig, mamoset and cynomolgus monkey [J]. BrJ Pharmacol, 2000, 131(7): 1262-74.
10[12]Bohm F, Pernow J. Urotensin Ⅱ evokes potent vasoconstriction in humans in vivo[J]. Br J Pharmacol, 2002, 135(1): 25-7.
